Dyne Therapeutics Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Focus SLDP Q1 2026 Earnings Solid Power Beats EPS Estimates by a Wide Margin PreRevenue Status Maintained ODYS Q1 2026 Earnings EPS Misses Estimates as Company Focuses on Product Development Meridian Corporation MRBK Q1 2026 Earnings EPS Misses Estimates but Stock Gains Slightly 51Talk COE Q3 2025 Earnings Net Loss Widens as Stock Declines Amid Quiet Quarter AGEN Earnings Overview 20260528